Life Science
Click to enlarge
Home » Our Report Repository » Antiviral Drugs Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis
Food Anti-Caking Agents market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis $ 3,475.00
Back to products
Automotive Market research
Vehicle Leasing Market Analysis and Forecast (2021-2028) with COVID Impact Analysis $ 3,475.00

Antiviral Drugs Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Global Antiviral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generic), By Application (HIV, Hepatitis, Herpes, Influenza, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_772| Page: 129 | Report Status: Upcoming

Categories: , Tags: , , , , , ,
Description

The global Antiviral Drugs market size is expected to reach $120.45 Billion by 2028 growing at the CAGR of 8.48% from 2021 to 2028. This growth is attributed to several macro and microeconomic factors such as

  • Increasing prevalence of viral infections such as hepatitis and HIV
  • Presence of pipeline products for HIV treatment
  • Increasing geriatric population

Further several factors restraining the market growth include

  • Presence of generics
  • Rising awareness and preventive treatments

Collaborations and Alliances in the Antiviral Drugs market are expected to generate higher avenues during the forecast period.

The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Antiviral Drugs market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

 In terms of COVID 19 impact, the Antiviral Drugs market report also includes the following data points:

  • Impact on Antiviral Drugs market size
  • End-User Trend, Preferences, and Budget Impact
  • Regulatory Framework/Government Policies
  • Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
  • Opportunity in Antiviral Drugs market

Key Insight in the report:

The global Antiviral Drugs market report covers executive summary, market dynamics, COVID impact & post COVID scenario, market size and forecast, competitive intelligence, market positioning, and product offerings.

Our report covers extensive competitive intelligence which includes the following data points:

  • Business Overview
  • Business Segment Data
  • Financial Data
  • Product Segment Analysis and Specification
  • Recent Development and Company Strategy Analysis
  • SWOT Analysis

The report covers market sizing and forecasting at the country level as well as at the segment level. The antiviral drugs market is analyzed across the below-mentioned different segments:

  • Drug Class
    • DNA Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Neuraminidase Inhibitors
    • Others
  • Type
    • Branded
    • Generic
  • Application
    • HIV
    • Hepatitis
    • Herpes
    • Influenza
    • Others

The Antiviral Drugs market is also analyzed across the below-mentioned regions/countries:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Rest of the World
    • South America
    • Middle East & Africa

Some of the key players in the Antiviral Drugs market include:

  • GlaxoSmithKline
  • AbbVie
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Aurobindo Pharma
  • Reddy’s Laboratories Ltd.
  • GlaxoSmithKline
  • Hoffmann-La Roche

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future market trends and opportunities
  • Detailed analysis on current market drivers, restraining factors, and opportunities in the future
  • Antiviral Drugs market estimates for 2020 and forecast from 2021 to 2028
  • Vendor market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding took an investment done, among others.

Target Audience

  • Manufacturers
  • Suppliers and traders
  • Government, associations, and industrial bodies
  • Investors and trade experts
  • Consulting Firms or Individual Consultant
  • Anyone interested in understanding the industry dynamics of the Antiviral Drugs market

For more details mail us at

Ask a question / additional requirement

Press Release

Table of Content

Table of Content

Chapter 1.   Executive Summary

Chapter 2.   Scope Of The Study

                     2.1.   Market Definition

                     2.2.   Scope Of The Study

                               2.2.1.   Objectives of Report

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat Of New Entrants

                               4.2.2.   Bargaining Power Of Buyers

                               4.2.3.   Bargaining Power Of Suppliers

                               4.2.4.   Threat Of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact of COVID-19 on Antiviral Drugs Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End User Trend, Preferences, and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DRO Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

Chapter 6.   Global Antiviral Drugs Market, By Drug Class

                     6.1.   Introduction

                     6.2.   DNA Polymerase Inhibitors

                     6.3.   Reverse Transcriptase Inhibitors

                       6.4.    Protease Inhibitors

                       6.5.    Neuraminidase Inhibitors

                       6.6.    Others

Chapter 7.   Global Antiviral Drugs Market, By Type

                     7.1.   Introduction

                     7.2.   Branded

                     7.3.   Generic

Chapter 8.   Global Antiviral Drugs Market, By Application

                     8.1.   Introduction

                     8.2.   HIV

                     8.3.   Hepatitis

                     8.4.   Herpes

                     8.5.   Influenza

                     8.6.   Others

Chapter 9.   Global Antiviral Drugs Market, By Region

                     9.1.   Introduction

                     9.2.   North America

                               9.2.1.   Introduction

                               9.2.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.2.4.   Market Size and Forecast, By Drug Class, 2020 - 2028

                               9.2.5.   Market Size and Forecast, By Type, 2020 - 2028

                               9.2.6.   Market Size and Forecast, By Application, 2020 - 2028

                               9.2.7.   US

                                              9.2.7.1.   Introduction

                                              9.2.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.2.7.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.2.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.2.7.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.2.8.   Canada

                                              9.2.8.1.   Introduction

                                              9.2.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.2.8.4.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.2.8.5.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.2.8.6.   Market Size and Forecast, By Application, 2020 - 2028

                     9.3.   Europe

                               9.3.1.   Introduction

                               9.3.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.3.4.   Market Size and Forecast, By Drug Class, 2020 - 2028

                               9.3.5.   Market Size and Forecast, By Type, 2020 - 2028

                               9.3.6.   Market Size and Forecast, By Application, 2020 - 2028

                               9.3.7.   Germany

                                              9.3.7.1.   Introduction

                                              9.3.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.7.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.3.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.3.7.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.3.8.   France

                                              9.3.8.1.   Introduction

                                              9.3.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.8.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.3.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.3.8.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.3.9.   UK

                                              9.3.9.1.   Introduction

                                              9.3.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.9.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.3.9.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.3.9.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.3.10.   Italy

                                              9.3.10.1.   Introduction

                                              9.3.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.10.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.3.10.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.3.10.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.3.11.   Rest Of Europe

                                              9.3.11.1.   Introduction

                                              9.3.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.3.11.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.3.11.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.3.11.5.   Market Size and Forecast, By Application, 2020 - 2028

                     9.4.   Asia-Pacific

                               9.4.1.   Introduction

                               9.4.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                               9.4.4.   Market Size and Forecast, By Drug Class, 2020 - 2028

                               9.4.5.   Market Size and Forecast, By Type, 2020 - 2028

                               9.4.7.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.8.   China

                                              9.4.8.1.   Introduction

                                              9.4.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.8.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.4.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.4.8.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.9.   India

                                              9.4.9.1.   Introduction

                                              9.4.9.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.9.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.4.9.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.4.9.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.10.   Japan

                                              9.4.10.1.   Introduction

                                              9.4.10.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.10.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.4.10.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.4.10.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.11.   South Korea

                                              9.4.11.1.   Introduction

                                              9.4.11.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.11.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.4.11.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.4.11.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.4.12.   Rest Of Asia-Pacific

                                              9.4.11.1.   Introduction

                                              9.4.12.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.4.12.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.4.12.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.4.12.5.   Market Size and Forecast, By Application, 2020 - 2028

                     9.5.   Rest Of The World (RoW)

                               9.5.1.   Introduction

                               9.5.2.   Driving Factors, Opportunity Analyzed and Key Trends

                               9.5.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                               9.5.4.   Market Size and Forecast, By Type, 2020 - 2028

                               9.5.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.5.6.   Market Size and Forecast, By Region, 2020 - 2028

                               9.5.7.   South America

                                              9.5.7.1.   Introduction

                                              9.5.7.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.5.7.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.5.7.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.5.7.5.   Market Size and Forecast, By Application, 2020 - 2028

                               9.5.8.   Middle East & Africa

                                              9.5.8.1.   Introduction

                                              9.5.8.2.   Driving Factors, Opportunity Analyzed and Key Trends

                                              9.5.8.3.   Market Size and Forecast, By Drug Class, 2020 - 2028

                                              9.5.8.4.   Market Size and Forecast, By Type, 2020 - 2028

                                              9.5.8.5.   Market Size and Forecast, By Application, 2020 - 2028

Chapter 10.   Competitive Landscape

                     10.1.   Introduction

                     10.2.   Vendor Share Analysis, 2020/Key Players Positioning 2020

Chapter 11.   Company Profiles

                     11.1.   GlaxoSmithKline

                               11.1.1.   Business Overview

                               11.1.2.   Financial Analysis

                               11.1.3.   Product Portfolio

                               11.1.4.   Recent Development and Strategies Adopted

                               11.1.5.   SWOT Analysis

                     11.2.   AbbVie

                               11.2.1.   Business Overview

                               11.2.2.   Financial Analysis

                               11.2.3.   Product Portfolio

                               11.2.4.   Recent Development and Strategies Adopted

                               11.2.5.   SWOT Analysis

                     11.3.   Merck & Co., Inc.

                               11.3.1.   Business Overview

                               11.3.2.   Financial Analysis

                               11.3.3.   Product Portfolio

                               11.3.4.   Recent Development and Strategies Adopted

                               11.3.5.   SWOT Analysis

                     11.4.   Johnson & Johnson Services, Inc.

                               11.4.1.   Business Overview

                               11.4.2.   Financial Analysis

                               11.4.3.   Product Portfolio

                               11.4.4.   Recent Development and Strategies Adopted

                               11.4.5.   SWOT Analysis

                     11.5.   Bristol-Myers Squibb Company

                               11.5.1.   Business Overview

                               11.5.2.   Financial Analysis

                               11.5.3.   Product Portfolio

                               11.5.4.   Recent Development and Strategies Adopted

                               11.5.5.   SWOT Analysis

                     11.6.   Cipla Inc.

                               11.6.1.   Business Overview

                               11.6.2.   Financial Analysis

                               11.6.3.   Product Portfolio

                               11.6.4.   Recent Development and Strategies Adopted

                               11.6.5.   SWOT Analysis

                     11.7.   Aurobindo Pharma

                               11.7.1.   Business Overview

                               11.7.2.   Financial Analysis

                               11.7.3.   Product Portfolio

                               11.7.4.   Recent Development and Strategies Adopted

                               11.7.5.   SWOT Analysis

                     11.8.   Dr. Reddy’s Laboratories Ltd.

                               11.8.1.   Business Overview

                               11.8.2.   Financial Analysis

                               11.8.3.   Product Portfolio

                               11.8.4.   Recent Development and Strategies Adopted

                               11.8.5.   SWOT Analysis

                     11.9.   GlaxoSmithKline

                               11.9.1.   Business Overview

                               11.9.2.   Financial Analysis

                               11.9.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

                     11.10.   F. Hoffmann-La Roche

                               11.10.1.   Business Overview

                               11.10.2.   Financial Analysis

                               11.10.3.   Product Portfolio

                               11.9.4.   Recent Development and Strategies Adopted

                               11.9.5.   SWOT Analysis

 

Chapter 12.   Key Takeaways

 

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Related products

Life Science

Cough Syrup Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Cough Syrup Market By Product Type (Combination Drugs, Individuals), By Category(Cough Suppressants, Expectorants) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_317| Page: 165 | Published Date: March 2021
Add to cart
Quick view
Life Science

Pain Management Drugs Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Pain Management Drugs Market By Drug Class(NSAIDs, Anesthetics, Anticonvulsants, Others), By Indication(Arthritic Pain, Neuropathic Pain, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_318| Page: 157 | Published Date: March 2021
Add to cart
Quick view
Life Science

Breast Cancer Liquid Biopsy Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Breast Cancer Liquid Biopsy Market By Circulating Biomarker(Circulating Tumor Cells, Cell-free DNA, Extracellular Vesicles, Others), By  End User ( Reference Laboratories, Hospitals and Physician Laboratories) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_312| Page: 156 | Published Date: March 2021
Add to cart
Quick view
Life Science

India Blood Product Market Analysis and Global Forecast (2021-2027) with COVID Impact Analysis

$ 3,475.00

Blood Product Market by Type (Coagulation Factor, Immune Globulin, Albumin), By Application (Surgery, Therapy, Immunity) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2007

Report Code: EB_LS_463| Page: 77 | Published Date: July 2021
Add to cart
Quick view
Life Science

Healthcare Education Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Healthcare Education Market By Application (Academic Education, Cardiology, Pediatrics, Others), By Delivery Mode (Classroom based courses, E-Learning solutions) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_337| Page: 168| Published Date: March 2021
Add to cart
Quick view
Life Science

Proteomics Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Proteomics Market By Component (Instruments, Reagents, Services,), By Application (Drug Discovery, Diseases Diagnosis) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_331 | Page: 162 | Published Date: March 2021
Add to cart
Quick view
Healthcare

Global Healthcare Blockchain Technology Market

$ 3,475.00
Healthcare Blockchain Technology Market By Type (Public and Private) By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, and Others) By End Use (Hospitals, Healthcare Payers, Healthcare Providers, Pharmaceutical Companies, and Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
Add to cart
Quick view
Life Science

Telmisartan Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Telmisartan Market By Indication (Hypertension and Cardiovascular Risk Reduction), By Distribution Channel(Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_313| Page: 164 | Published Date: March 2021
Add to cart
Quick view